Epigallocatechin Gallate (EGCG) — Research Profile

At moderate doses taken with food (200-500mg EGCG), green tea extract is generally safe. However, high doses (800mg+) taken on an empty stomach have caused liver injury in documented cases. The European Food Safety Authority recommends not exceeding 800mg EGCG daily from supplements. Always take green tea extract with food and avoid fasted dosing to minimize hepatotoxicity risk.

A cup of green tea provides approximately 50-100mg EGCG. Drinking 3-5 cups daily delivers 150-500mg EGCG in a natural matrix with L-theanine and other catechins. This is comparable to standard supplement doses and may be safer due to slower absorption. However, supplements offer convenience and precise dosing. Matcha provides the highest EGCG per cup since you consume the whole leaf.

Yes. EGCG chelates non-heme iron (plant-based and supplemental iron), reducing its absorption by up to 25%. If you have iron deficiency or take iron supplements, separate EGCG intake from iron-rich meals or supplements by at least 2 hours. This does not affect heme iron from meat sources.

From a safety standpoint brewed green tea infusions are the better-supported form: EFSA found no indication of liver damage from hot-water-brewed, instant, or ready-to-drink green tea, whereas the reported cases of hepatotoxicity are concentrated almost entirely in extract capsules and tablets. If you do use a concentrated extract, LiverTox notes the US Pharmacopoeia committee recommends taking it with meals. That advice fits the pharmacokinetics: in a controlled crossover trial, taking green tea catechins on an empty stomach produced more than a 3.5-fold higher peak EGCG blood level than taking the same dose with food, so a fasted extract delivers a much larger EGCG spike.

The best-supported effects are modest. A 2025 meta-analysis linked green tea to a small reduction in overall cancer risk (RR 0.91) with a stronger signal for isolated EGCG (RR 0.72), most consistent for prostate, oral, gallbladder, and hematological cancers. Separately, EGCG produced a small drop in HbA1c (-0.18%), and NCCIH characterizes its weight and cholesterol effects as small. Notably, a randomized trial found no cognitive benefit in children with Down syndrome, so benefits are real but incremental rather than dramatic.

No standardized therapeutic dose is established, and trials have used widely varying amounts for different endpoints. The clearest number is a safety ceiling rather than a target: EFSA identified 800 mg of supplemental EGCG per day as the level associated with signs of liver injury and could not confirm a proven safe dose below it. Practically, staying well under 800 mg EGCG/day from supplements, and getting catechins from brewed tea where possible, is the evidence-based framing.

Time of day has not been directly compared for efficacy, so the meaningful guidance is about safety, not clock time. LiverTox notes the US Pharmacopoeia committee recommends taking green tea extract with meals, and a controlled pharmacokinetic trial found that taking it on an empty stomach raised peak EGCG blood levels more than 3.5-fold versus taking it with food, so pairing an extract with a meal blunts that exposure spike. Because extracts also contain caffeine, taking them earlier in the day is reasonable if evening stimulation affects your sleep.

According to NCCIH, green tea extract supplements can cause nausea, constipation, abdominal discomfort, and increased blood pressure. The rare but serious concern is liver injury: EFSA and LiverTox tie this mainly to supplemental EGCG at or above 800 mg/day, presenting as an acute hepatitis-like picture 1 to 6 months after starting and usually resolving once the product is stopped. Signs such as fatigue, dark urine, or yellowing skin warrant stopping the supplement promptly.

Yes. NCCIH reports that green tea can lower blood levels and reduce the effectiveness of nadolol (a beta-blocker for blood pressure), atorvastatin (a cholesterol drug), and raloxifene (used for osteoporosis). Given the documented risk of liver enzyme elevation from concentrated EGCG, combining it with other medications that stress the liver also warrants caution. Anyone on these drugs should confirm suitability before using green tea extract.

EGCG is most reasonable for people seeking modest cardiometabolic support, given its small effects on HbA1c and cholesterol, though brewed green tea is a safer way to obtain it than high-dose extracts. It is a poor fit for anyone with liver disease, those taking nadolol, atorvastatin, or raloxifene, and pregnant or breastfeeding people, for whom supplemental catechin safety is not established. People who carry the HLA-B*35:01 variant (5-15% of the population) face a higher idiosyncratic liver-injury risk from concentrated EGCG.

There is no single onset because EGCG's measurable effects depend entirely on the endpoint. Metabolic markers such as HbA1c shift only slightly over weeks of daily supplementation (a meta-analysis of 41 trials found just a -0.18% reduction), while the cancer-risk associations come from years of habitual green tea intake in cohort studies. In a 6-month randomized trial in children with Down syndrome, EGCG produced no cognitive improvement at all, so a fast, noticeable 'result' should not be expected from EGCG alone.

EFSA's 2018 safety review concluded that green tea extract supplements delivering 800 mg or more of EGCG per day for four months or longer were associated with elevated liver enzymes (ALT/AST) in a small share of users (usually under 10%), and it could not identify a proven safe supplement dose below that threshold. Brewed green tea infusions, by contrast, showed no such liver signal even at high intake. For long-term use, the concentrated extract form is the concern, not tea itself.

Yes. The dose-limiting risk is idiosyncratic liver injury: EFSA flags supplemental EGCG at or above 800 mg/day as associated with liver-enzyme elevations. LiverTox reports that injury typically appears 1 to 6 months after starting (median about 42 days) and is strongly linked to the HLA-B*35:01 gene variant, present in 5-15% of people. It is usually reversible after stopping, with case series showing recovery over roughly two months.

Combining green tea extract with other botanicals is the main caution: a case series of green tea hepatotoxicity found that multi-ingredient products were tied to markedly longer liver-injury recovery (about 119 days versus 65 days for green tea alone). One frequently cited worry, that EGCG depletes folate, was not borne out in a trial where 720 mg/day for 30 days kept folate in the normal range even alongside fertility drugs. Because extracts add to your total EGCG load, stacking several catechin-containing products raises the cumulative dose toward the 800 mg/day concern level.

Choose a product that states the actual EGCG milligrams per serving, since the entire safety framework is built around cumulative EGCG dose rather than vague 'green tea extract' weight. Keeping your daily EGCG below EFSA's 800 mg concern threshold is the key number to check on the label. Because extracts can also carry caffeine, look for a caffeine disclosure (or a decaffeinated product) and independent third-party testing for identity and contaminants.